{"id":2383,"date":"2021-03-24T10:35:19","date_gmt":"2021-03-24T09:35:19","guid":{"rendered":"https:\/\/blogs.tu-braunschweig.de\/pubpharm\/?p=2383"},"modified":"2021-05-04T09:40:49","modified_gmt":"2021-05-04T07:40:49","slug":"dphg-phd-students-postdocs-meeting-2021-praesentation-des-fid-pharmazie","status":"publish","type":"post","link":"https:\/\/blog.pubpharm.de\/index.php\/2021\/03\/24\/dphg-phd-students-postdocs-meeting-2021-praesentation-des-fid-pharmazie\/","title":{"rendered":"DPhG &#8211; PhD students\/Postdocs Meeting 2021: Pr\u00e4sentation des FID Pharmazie"},"content":{"rendered":"<p>Vom 11.03. bis zum 12.03.2021 fand das diesj\u00e4hrige <a href=\"https:\/\/www.dphg.de\/aktivitaeten\/tagungen\/doktorandentagung2021\/\" target=\"_blank\" rel=\"noopener noreferrer\">PhD students\/Postdocs Meeting der Deutschen Pharmazeutischen Gesellschaft<\/a> als virtuelle Veranstaltung statt. In einem Kurzvortrag pr\u00e4sentierte der FID Pharmazie aktuelle <a href=\"https:\/\/www.pubpharm.de\/vufind\/\" target=\"_blank\" rel=\"noopener noreferrer\">PubPharm<\/a>-Inhalte und -Funktionen. Erg\u00e4nzend wurden die <a class=\"belugax-low-link\" href=\"http:\/\/fid-forum.ifis.cs.tu-bs.de:8080\/drugstats\/fid-graph\/graphscript\/ai-access_2021_ee_5.html#\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Drug-Disease-Networks <\/a>\u00a0als neues innovatives PubPharm-Feature vorgestellt.<\/p>\n<p>Alle Interessierten k\u00f6nnen das Handout zur Pr\u00e4sentation bis zum 30.04.2021 abrufen.<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-2389\" src=\"https:\/\/blog.pubpharm.de\/wp-content\/2021\/03\/Screenshot_DDN_Venlafaxin.png\" alt=\"\" width=\"1895\" height=\"893\" srcset=\"https:\/\/blog.pubpharm.de\/wp-content\/uploads\/2021\/03\/Screenshot_DDN_Venlafaxin.png 1895w, https:\/\/blog.pubpharm.de\/wp-content\/uploads\/2021\/03\/Screenshot_DDN_Venlafaxin-300x141.png 300w, https:\/\/blog.pubpharm.de\/wp-content\/uploads\/2021\/03\/Screenshot_DDN_Venlafaxin-768x362.png 768w, https:\/\/blog.pubpharm.de\/wp-content\/uploads\/2021\/03\/Screenshot_DDN_Venlafaxin-1024x483.png 1024w, https:\/\/blog.pubpharm.de\/wp-content\/uploads\/2021\/03\/Screenshot_DDN_Venlafaxin-712x336.png 712w, https:\/\/blog.pubpharm.de\/wp-content\/uploads\/2021\/03\/Screenshot_DDN_Venlafaxin-1320x622.png 1320w\" sizes=\"auto, (max-width: 1895px) 100vw, 1895px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vom 11.03. bis zum 12.03.2021 fand das diesj\u00e4hrige PhD students\/Postdocs Meeting der Deutschen Pharmazeutischen Gesellschaft als virtuelle Veranstaltung statt. In einem Kurzvortrag pr\u00e4sentierte der FID Pharmazie aktuelle PubPharm-Inhalte und -Funktionen. Erg\u00e4nzend wurden die Drug-Disease-Networks \u00a0als neues innovatives PubPharm-Feature vorgestellt. Alle Interessierten k\u00f6nnen das Handout zur Pr\u00e4sentation bis zum 30.04.2021 abrufen. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [&hellip;]<\/p>\n","protected":false},"author":179,"featured_media":1353,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,7,8,9],"tags":[],"class_list":["post-2383","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein","category-pubpharm-features","category-pubpharm-praesentation","category-pubpharm-rechercheplattform"],"_links":{"self":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts\/2383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/users\/179"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/comments?post=2383"}],"version-history":[{"count":8,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts\/2383\/revisions"}],"predecessor-version":[{"id":2429,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts\/2383\/revisions\/2429"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/media\/1353"}],"wp:attachment":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/media?parent=2383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/categories?post=2383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/tags?post=2383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}